Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Hormone-Dependent Neoplasms. Found 12 abstracts

Harshman LC, Chen YH, Liu G, Carducci MA, Jarrard D, Dreicer R, Hahn N, Garcia JA, Hussain M, Shevrin D, Eisenberger M, Kohli M, Plimack ER, Cooney M, Vogelzang NJ, Picus J, Dipaola R, Sweeney CJ. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol. 2018 Feb;36(4):376-82.   PMCID: PMC5805480
Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Cooney MM, Garcia JA, DiPaola RS, Sweeney CJ. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial. J Clin Oncol. 2018 Apr 10;36(11):1080-7.   PMCID: PMC5891129
Fan L, Liedke PE, Isakoff SJ, St Louis J, Ryan PD, Goss PE. Intermittent letrozole therapy for metastatic breast cancer: case reports and literature review. Clin Breast Cancer. 2014 Apr;14(2):e41-5.
Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Clinical Cancer Research. 2010 Mar 15;16(6):1904-14.   PMCID: NIHMS352308
Meireles SI, Esteves GH, Hirata R, Peri S, Devarajan K, Slifker M, Mosier SL, Peng J, Vadhanam MV, Hurst HE, Neves EJ, Reis LF, Gairola CG, Gupta RC, Clapper ML. Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue. Cancer prevention research (Philadelphia, Pa). 2010 Jun;3(6):707-17.   PMCID: PMC2896420
Chen JQ, Cammarata PR, Baines CP, Yager JD. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochimica et biophysica acta. 2009 Oct;1793(10):1540-70.   PMCID: PMC2744640
Freedman GM, Anderson PR, Li T, Nicolaou N. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer. 2009 Mar;115(5):946-51.   PMCID: PMC2993502
Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory. Journal of Clinical Oncology. 2008 May 20;26(15):2473-81.
Cianfrocca M, Goldstein LJ. Operable breast cancer. Current treatment options in oncology. 2001 Apr;2(2):157-67.
Obasaju C, Manola J, Hudes GR, Khandekar JD, Citrin DL, Carbone P, Trump DL. Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr;24(2):150-4.
Haas NB, Manola J, Hudes G, Citrin DL, Kies MS, Davis TE. Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer. Am J Clin Oncol. 2000 Dec;23(6):589-92.
Hudes G. Estramustine-based chemotherapy. Semin Urol Oncol. 1997 Feb;15(1):13-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Hormone-Dependent Neoplasms

Hormone-Dependent Neoplasms drug therapy therapeutic use Female pathology Breast Neoplasms metabolism Male administration & dosage Antineoplastic Combined Chemotherapy Protocols Estrogen Receptors Prostatic Neoplasms Aged Human Middle Aged 80 and over Aged Treatment Outcome Neoplasm Metastasis mortality US Gov't Support-PHS secondary adverse effects Time Factors Adult Survival Analysis genetics radiotherapy Nitriles erbB-2 Receptor physiology Prognosis surgery Estrogens Neoplasm Staging Androgen Antagonists Prospective Studies Progesterone Receptors Combined Modality Therapy pharmacology Estradiol etiology Doxorubicin Triazoles Local Neoplasm Recurrence Docetaxel drug effects Estramustine Menogaril Gene Regulatory Networks Antineoplastic Antibiotics Retrospective Studies Random Allocation Quinazolines pharmacokinetics Tamoxifen administration & Fluorouracil Neoplasm Drug Resistance Aryl Hydrocarbon Hydroxylases derivatives Inbred A Mice Parkinson Disease Apoptosis Mitochondrial DNA Discontinuous therapy Ductal Carcinoma-Breast Segmental Mastectomy Lung Neoplasms diagnosis analogs & Antineoplastic Combined Chemotherapy Lobular Carcinoma Atmosphere Exposure Chambers Biological Markers Non-US Gov't Support Kallikreins enzymology Genetic Transcription Immunoenzyme Techniques Mitochondrial Proton-Translocating ATPases Gene Expression Regulation Tobacco Smoke Pollution Crystalline Lens Middle Age Gene Expression Profiling Mitochondrial Proteins Aromatase inhibitor blood Cisplatin Methotrexate Disease-Free Survival Cardiovascular Diseases Lymphatic Metastasis Prostate-Specific Antigen Enzyme Induction Postmenopause Protein Biosynthesis Cryptochromes Clinical Trials Aromatase Inhibitors Phase II Clinical Trials as Topic Survival Rate Multicenter Studies as Topic Mice Factual Databases Progesterone Oligonucleotide Array Sequence Analysis Tissue Distribution Antitumor Drug Screening Assays Cell Proliferation Electron Transport Smoking Neuroprotective Agents Microsomes control Alzheimer Disease dosage Mitochondrial Genome Pilot Projects Protocols Messenger RNA Biological Models Randomized Controlled Trials as Topic Reverse Transcriptase Polymerase Chain Reaction biosynthesis Mitochondria Hormonal Antineoplastic Agents Epidermal Growth Factor Receptor Disease resistance Lung Adenocarcinoma Double-Blind Method Review Literature as Topic prevention & Neoadjuvant Therapy Practice Guidelines
Last updated on Friday, August 07, 2020